 |
|
Home | SunTrust Starts Coverage on Trius Therapeutics (TSRX) |
 |
SunTrust Starts Coverage on Trius Therapeutics (TSRX)
|
 |
- June 15, 2012
-
Investment analysts at SunTrust began coverage on shares of Trius Therapeutics (NASDAQ: TSRX) in a note issued to investors on Friday. The firm set a “buy” rating on the stock. Trius Therapeutics opened at 5.09 on Friday. Trius Therapeutics has a 1-year low of $4.71 and a 1-year high of $9.00. The company’s market cap [...]This article (SunTrust Starts Coverage on Trius Therapeutics (TSRX)) was originally developed by and is property of American Banking News. Checkout American Banking News for up-to-date banking news and peer to peer lending news.
- Read more at:http://www.americanbankingnews.com/2012/06/15/suntrust-starts-coverage-on-trius-therapeutics-tsrx/
|
 |
|
 |
|
 |
